Exogene is an Oxford-based, venture-backed biotechnology company using a proprietary lab-in-the-loop AI platform to design novel, multi-specific immune engager drugs targeting peptide-HLA antigens to eradicate cancer.
| Website | https://exogene.co.uk/ |
| Employees | 15 (14 on RocketReach) |
| Phone | +1 212-645-3300 |
| Technologies | |
| Industry | Biotechnology |
| Keywords | Biotechnology, Cancer Therapies, Immunotherapy, Generative Ai, High-Throughput Screening, Drug Discovery, Therapeutics, Precision Medicine, Oncology, Solid Tumors, Biotechnology Research, Pharmaceutical Research, Molecular Biology, Cell Therapy, Cancer Research, Clinical Trials, Biomedical Engineering |
Looking for a particular Exogene Ltd. employee's phone or email?
Federico Paoletti is the CEO and Co-Founder of Exogene Ltd..
14 people are employed at Exogene Ltd..